A trial cut hospital admissions by 72 per cent
Notifications can be managed in browser preferences.
Swipe for next article
A trial cut hospital admissions by 72 per cent
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids
Until now, patients have had to spend hours on a drip to get the drug pembrolizumab (Keytruda) to treat their cancer.
The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments
Teplizumab can allow patients to live “normal lives” without the need for insulin injections
Patients may eventually access weight-loss jabs at pharmacies in a drive to ‘turn the tide’ on rising obesity, Professor Sir…
Combination of two drugs already available on the NHS could give patients extra months of life, study finds
